VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRAXPraxis Precision Medicines, Inc.
$327.79$9.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPRAXQuarterly Cash Flow

Praxis Precision Medicines, Inc. (PRAX) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Praxis Precision Medicines, Inc. (PRAX) quarterly cash flow statement — complete operating, investing & financing history

PRAX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Cash from Operations-86.05M-77.26M-64.74M-54.68M-52.71M-56.12M-27.5M-27.28M-20.59M-23.6M-22.96M-30.96M
Operating CF Margin %------752%-9105.96%-7640.9%-4776.33%-4582.52%-4906.2%-3964.66%
Operating CF Growth %-63.26%-37.66%-135.41%-100.44%-156.03%-137.81%-19.77%11.9%36.86%17.4%48.63%45.57%
Net Income-92.56M-88.91M-73.93M-71.13M-69.3M-58.68M-51.91M-32.68M-39.55M-26.88M-24.63M-34.31M
Depreciation & Amortization39K28K19K-941K47K47K-3.53M107K112K111K321K312K
Stock-Based Compensation007.45M7.77M8.79M8.57M12.43M5.88M14.47M5.73M00
Deferred Taxes000000000000
Other Non-Cash Items16.65M9.53M-442K257K-980K-1.15M17.69M-1.3M2.64M218K5.76M5.78M
Working Capital Changes-10.18M2.09M2.17M9.37M8.74M-4.92M-2.18M715K1.74M-2.78M-4.41M-2.74M
Change in Receivables000000000000
Change in Inventory000000000000
Change in Payables6.53M-6.19M1.99M5.92M10.38M-2.48M7.01M-1.4M3.59M-1.3M-894K-8.98M
Cash from Investing-344.27M-328.39M50.41M17.89M-51.06M-10.92M49.57M-195.92M-91.22M-50K05M
Capital Expenditures-62K00-120K00000-50K00
CapEx % of Revenue---------9.71%--
Acquisitions000000000000
Investments------------
Other Investing00064K00000000
Cash from Financing609.33M613.45M6.44M28.63M53.97M113.77M1.44M216.36M182.49M3.87M-254K69.42M
Debt Issued (Net)-101K933K-319K-311K-303K835K0-278K-271K-261K-254K-250K
Equity Issued (Net)622.35M613.34M6.81M28.65M55.46M113.92M1.24M216.06M182.89M4.13M1K69.68M
Dividends Paid000000000000
Share Repurchases000000-1K00000
Other Financing-12.92M-819K-52K288K-1.2M-992K200K580K-137K-5K-1K-4K
Net Change in Cash179M207.8M-7.89M-8.15M-49.8M46.73M23.5M-6.84M70.68M-19.79M-23.21M43.46M
Free Cash Flow-86.11M-77.26M-64.74M-54.8M-52.71M-56.12M-27.5M-27.28M-20.59M-23.65M-22.96M-30.96M
FCF Margin %------752%-9105.96%-7640.9%-4776.33%-4592.23%-4906.2%-3964.66%
FCF Growth %-63.38%-37.66%-135.41%-100.88%-156.03%-137.3%-19.77%11.9%36.86%17.23%48.68%45.67%
FCF per Share-2.98-3.43-2.95-2.55-2.50-2.81-1.46-1.45-1.48-2.61-2.54-6.66
FCF Conversion (FCF/Net Income)0.93x0.87x0.88x0.77x0.76x0.96x0.53x0.83x0.52x0.88x0.93x0.90x
Interest Paid000000000000
Taxes Paid000000000000